ANTHONY ADEKUNLE: Open Payments
NPI 1659044204 · GEORGETOWN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 15 payments from 5 companies in 2025. Trend: 2023 $313 · 2024 $280 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $86 |
| Neurocrine BioSciences, Inc. | 4 | $68 |
| ABBVIE INC. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
Products named: INGREZZA, UZEDY, VRAYLAR, ABILIFY MAINTENA, COBENFY, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across DE — which companies pay providers there.
